PEOPLE ON THE MOVE
MedAvante bags new VP of R&D Michael Ropacki
Michael T. Ropacki has been appointed Vice President, Research and Development at MedAvante, Inc.
MedAvante is the global clinical data services company dedicated to maximizing signal detection in clinical trials based in Hamilton, New Jersey.
As VP of R&D, Michael will serve as the therapeutic leader for psychiatry, intensifying the company's traditional focus on mood and anxiety disorders, as well as new therapeutic areas.
Miahcel is also a NIH advisor to the National Institute on Aging (NIA), National Institute of Neurologic Disorders and Stroke (NINDS) and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).